DPW
PCVX icon

DiNuzzo Private Wealth’s Vaxcyte PCVX Stock Holding History

DiNuzzo Private Wealth’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175 Buy
+3
New +$163 ﹤0.01% 1261
2025
Q1 		– Sell
-1
Closed -$82 – 1411
2024
Q4 		$82 Buy
+1
New +$99 ﹤0.01% 1348

Other funds holding PCVX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

DiNuzzo Private Wealth's PCVX Position: Q2 2026 in Review

DiNuzzo Private Wealth opened a new position in Vaxcyte (PCVX) in Q2 2026: 3 shares worth $175. The stake represents ﹤0.01% of the portfolio and ranks #1261 among its holdings. This is a return to the name: DiNuzzo Private Wealth previously reported a position in PCVX as recently as Q4 2024.

DiNuzzo Private Wealth first reported a position in PCVX in Q4 2024 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • DiNuzzo Private Wealth held 3 shares of Vaxcyte worth $175 as of Q2 2026.
  • Vaxcyte was a new DiNuzzo Private Wealth position in Q2 2026.
  • Vaxcyte made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1261 holding.
  • DiNuzzo Private Wealth first reported a position in Vaxcyte in Q4 2024 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.